Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Perrigo (NY: PRGO ) 26.81 -0.12 (-0.45%) Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Perrigo < Previous 1 2 3 4 Next > $4.5M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying May 26, 2023 Although US stocks closed mostly higher on Thursday, there were a few notable insider trades. Via Benzinga Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement May 09, 2023 Via Benzinga FDA Raises Concerns Regarding Perrigo's OTC Birth Control Pill, Casts Doubts Over Real-World Use May 08, 2023 The FDA's Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) will be meeting this week to review Perrigo Company... Via Benzinga FDA Sets New Adcomm Date To Review Perrigo's Oral Contraceptive Pill For OTC Use March 28, 2023 Via Benzinga Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage March 21, 2023 House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. Via Benzinga Insiders Selling Perrigo And 3 Other Stocks March 10, 2023 The Nasdaq Composite dropped by around 2% on Thursday. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Earnings Outlook For Perrigo Co February 24, 2023 Via Benzinga Why Perrigo Stock Tanked on Tuesday November 08, 2022 A double miss and a guidance cut badly affected investor sentiment. Via The Motley Fool FDA Postpones Review Meeting For First OTC Contraceptive Option From Perrigo October 26, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 March 07, 2023 Via Benzinga 7 Perfect Presents to Gift Your 2023 Stock Portfolio December 21, 2022 As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023. Via InvestorPlace SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON December 16, 2022 Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving From ACO Via GlobeNewswire Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates May 11, 2022 Via Benzinga Earnings Scheduled For May 11, 2022 May 11, 2022 Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. Via Benzinga Earnings Scheduled For February 27, 2023 February 27, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. Via Benzinga Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday November 09, 2022 Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. Via Benzinga Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session November 08, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... Via Benzinga Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday November 08, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance November 08, 2022 Via Benzinga FDA Schedules AdComm Review For First Over The Counter Birth Control Pill September 13, 2022 Via Benzinga Is Sanofi A Buy, Despite Recent Stumbles? August 19, 2022 Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 September 14, 2022 Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... Via Benzinga Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim July 12, 2022 Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating. Via Investor's Business Daily Perrigo Seeks FDA Approval For the First OTC Contraceptive Pill July 11, 2022 Perrigo Company plc's (NYSE: PRGO) HRA Pharma has Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 September 06, 2022 Upgrades Via Benzinga The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death July 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For August 9, 2022 August 09, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. Via Benzinga This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives June 27, 2022 The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical... Via Benzinga Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage May 16, 2022 Singer and actress Bette Midler received a round of boos on Twitter Inc (NYSE: TWTR) after volunteering the idea that American women impacted by the ongoing baby formula shortage turn to... Via Benzinga Cannabis Movers & Shakers: MedMen's New CEO, TerrAscend, FoliuMed, Charlotte's Web & Proof Announce Appointments April 29, 2022 MedMen Names New CEO Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed a new CEO, Edward Record, who has been serving on the company's board since 2021. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
